Back to Search Start Over

The EHA Research Roadmap

Authors :
Jaffredo, Thierry
Balduini, Alessandra
Bigas, Anna
Bernardi, Rosa
Bonnet, Dominique
Canque, Bruno
Charbord, Pierre
Cumano, Anna
Delwel, Ruud
Durand, Charles
Fibbe, Willem
Forrester, Lesley
De Franceschi, Lucia
Ghevaert, Cedric
Gjertsen, Bjørn
Gottgens, Berthold
Graf, Thomas
Heidenreich, Olaf
Hermine, Olivier
Higgs, Douglas
Kleanthous, Marina
Klump, Hannes
Kouskoff, Valerie
Krause, Daniela
Lacaud, George
Celso, Cristina Lo
Martens, Joost H.A.
Méndez-Ferrer, Simón
Menendez, Pablo
Oostendorp, Robert
Philipsen, Sjaak
Porse, Bo
Raaijmakers, Marc
Robin, Catherine
Stunnenberg, Henk
Theilgaard-Mönch, Kim
Touw, Ivo
Vainchenker, William
Corrons, Joan-Lluis Vives
Yvernogeau, Laurent
Schuringa, Jan Jacob
Celso, Cristina
Martens, Joost
Schuringa, Jan
Laboratoire de Biologie du Développement [IBPS] (LBD)
Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Paris Seine (IBPS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Università degli Studi di Pavia = University of Pavia (UNIPV)
IMIM-Hospital del Mar
Generalitat de Catalunya
Josep Carreras Leukaemia Research Institute (IJC)
Instituto de Salud Carlos III [Madrid] (ISC)
IRCCS San Raffaele Scientific Institute [Milan, Italie]
The Francis Crick Institute [London]
Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Institut de Recherche Saint-Louis - Hématologie Immunologie Oncologie (Département de recherche de l’UFR de médecine
ex- Institut Universitaire Hématologie-IUH) (IRSL)
Université Paris Cité (UPCité)
Lymphopoïèse (Lymphopoïèse (UMR_1223 / U1223 / U-Pasteur_4))
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Erasmus University Medical Center [Rotterdam] (Erasmus MC)
Leiden University Medical Center (LUMC)
Universiteit Leiden
University of Edinburgh
Università degli studi di Verona = University of Verona (UNIVR)
University of Cambridge [UK] (CAM)
Haukeland University Hospital
University of Bergen (UiB)
Barcelona Institute of Science and Technology (BIST)
Universitat Pompeu Fabra [Barcelona] (UPF)
Princess Máxima Center for Pediatric Oncology [Utrecht, Netherlands]
Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163)
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
John Radcliffe Hospital [Oxford University Hospital]
Cyprus Institute of Neurology and Genetics
Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen)
University of Manchester [Manchester]
Goethe-Universität Frankfurt am Main
Georg-Speyer-Haus
Imperial College London
Radboud University [Nijmegen]
NHSBT
Universitat de Barcelona (UB)
Institució Catalana de Recerca i Estudis Avançats (ICREA)
Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM)
University of Copenhagen = Københavns Universitet (UCPH)
Hubrecht Institute [Utrecht, Netherlands]
University Medical Center [Utrecht]-Royal Netherlands Academy of Arts and Sciences (KNAW)
University Medical Center [Utrecht]
Institut Gustave Roussy (IGR)
Dynamique moléculaire de la transformation hématopoïétique (Dynamo)
Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
University Medical Center Groningen [Groningen] (UMCG)
Institut de Biologie Paris Seine (IBPS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)
Università degli Studi di Pavia
Laboratoire d'Innovation Thérapeutique (LIT)
Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut de Chimie du CNRS (INC)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)
Université de Paris (UP)
Laboratoire de Biologie du Développement [Paris] (LBD)
Institut Pasteur [Paris]
Hubrecht Institute for Developmental Biology and Stem Cell Research
Ghevaert, Cedric [0000-0002-9251-0934]
Gottgens, Berthold [0000-0001-6302-5705]
Apollo - University of Cambridge Repository
Stem Cell Aging Leukemia and Lymphoma (SALL)
Source :
Jaffredo, T, Balduini, A, Bigas, A, Bernardi, R, Bonnet, D, Canque, B, Charbord, P, Cumano, A, Delwel, R, Durand, C, Fibbe, W, Forrester, L, de Franceschi, L, Ghevaert, C, Gjertsen, B, Gottgens, B, Graf, T, Heidenreich, O, Hermine, O, Higgs, D, Kleanthous, M, Klump, H, Kouskoff, V, Krause, D, Lacaud, G, Celso, C L, Martens, J H A, Méndez-Ferrer, S, Menendez, P, Oostendorp, R, Philipsen, S, Porse, B, Raaijmakers, M, Robin, C, Stunnenberg, H, Theilgaard-Mönch, K, Touw, I, Vainchenker, W, Corrons, J-L V, Yvernogeau, L & Schuringa, J J 2021, ' The EHA Research Roadmap: Normal Hematopoiesis ', HemaSphere, vol. 5, no. 12, e669 . https://doi.org/10.1097/HS9.0000000000000669, HemaSphere, HemaSphere, 2021, 5 (12), pp.e669. ⟨10.1097/hs9.0000000000000669⟩, HemaSphere, Lippincott, Williams & Wilkins, 2021, 5 (12), pp.e669. ⟨10.1097/hs9.0000000000000669⟩, HemaSphere, 5(12). Wolters Kluwer Health, HemaSphere, Vol 5, Iss 12, p e669 (2021), Hemasphere, 5, HemaSphere, 5(12):669. LIPPINCOTT WILLIAMS & WILKINS, Hemasphere, 5, 12, Jaffredo, T, Balduini, A, Bigas, A, Bernardi, R, Bonnet, D, Canque, B, Charbord, P, Cumano, A, Delwel, R, Durand, C, Fibbe, W, Forrester, L, De Franceschi, L, Ghevaert, C, Gjertsen, B, Gottgens, B, Graf, T, Heidenreich, O, Hermine, O, Higgs, D, Kleanthous, M, Klump, H, Kouskoff, V, Krause, D, Lacaud, G, Lo Celso, C, Martens, J H A, Méndez-Ferrer, S, Menendez, P, Oostendorp, R, Philipsen, S, Porse, B, Raaijmakers, M, Robin, C, Stunnenberg, H, Theilgaard-Mönch, K, Touw, I, Vainchenker, W, Corrons, J L V, Yvernogeau, L & Schuringa, J J 2021, ' The eha research roadmap : normal hematopoiesis ', HemaSphere, vol. 5, no. 12, e669 . https://doi.org/10.1097/HS9.0000000000000669
Publication Year :
2021
Publisher :
LIPPINCOTT WILLIAMS & WILKINS, 2021.

Abstract

International audience; In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1–2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

Details

Language :
English
ISSN :
25729241
Volume :
5
Issue :
12
Database :
OpenAIRE
Journal :
HemaSphere
Accession number :
edsair.doi.dedup.....fe6d9a03ca46b1596fd8486650ae670b
Full Text :
https://doi.org/10.1097/HS9.0000000000000669